Hallberg E, Rydström J
Department of Biochemistry, Arrhenius Laboratory, University of Stockholm, Sweden.
Toxicology. 1987 Dec 14;47(3):259-75. doi: 10.1016/0300-483x(87)90056-4.
The adrenocorticolytic agent DMBA and its liver metabolite, 7-OHM-12-MBA, were investigated with respect to their mechanism of toxicity in cultured rat adrenal cells. Under proper growth conditions both hydrocarbons caused a reproducible and ACTH-dependent inhibition of steroidogenesis and cell death, similar to the effects of these agents on the rat adrenal in vivo. The toxicity of both DMBA and 7-OHM-12-MBA was partially prevented by antioxidants suggesting a common peroxidative mechanism of action. Studies with cytochrome P-450 inhibitors showed that toxicity of DMBA, but not 7-OHM-12-MBA, required a cytochrome P-450-dependent metabolic activation in order to be toxic. In addition, metyrapone, an efficient and specific inhibitor of the mitochondrial 11 beta-hydroxylase, provided protection against DMBA-induced toxicity, which is in agreement with previous observations that adrenal necrosis caused by DMBA apparently originates in mitochondria. It is proposed that both 7-OHM-12-MBA and DMBA, the latter after metabolism to mainly phenols, act as pseudosubstrates for steroid hydroxylases and initiate peroxidative damage through hydroxylase-generated superoxide anion, and/or hydrogen peroxide. These results indicate that both adrenal and hepatic metabolism of DMBA are potentially important in DMBA-induced adrenocorticolysis in vivo.
研究了肾上腺皮质溶解剂二甲基苯蒽(DMBA)及其肝脏代谢产物7-羟基-12-甲基苯蒽(7-OHM-12-MBA)对培养的大鼠肾上腺细胞的毒性作用机制。在适宜的生长条件下,这两种碳氢化合物都会引起可重复的、促肾上腺皮质激素(ACTH)依赖性的类固醇生成抑制和细胞死亡,类似于这些药物在体内对大鼠肾上腺的作用效果。抗氧化剂可部分预防DMBA和7-OHM-12-MBA的毒性,提示其具有共同的过氧化作用机制。细胞色素P-450抑制剂研究表明,DMBA的毒性需要细胞色素P-450依赖性的代谢活化才能产生毒性,而7-OHM-12-MBA则不然。此外,甲吡酮是线粒体11β-羟化酶的有效且特异性抑制剂,它能保护细胞免受DMBA诱导的毒性,这与之前关于DMBA引起的肾上腺坏死明显起源于线粒体的观察结果一致。有人提出,7-OHM-12-MBA和DMBA(后者代谢后主要生成酚类)都作为类固醇羟化酶的假底物,并通过羟化酶产生的超氧阴离子和/或过氧化氢引发过氧化损伤。这些结果表明,DMBA在肾上腺和肝脏的代谢在其体内诱导的肾上腺皮质溶解过程中可能都很重要。